Eleusis
third party oral proof of concept studies in and treatment resistant depression rapid robust and durable efficacy observed but significant room for improvement | Eleusis
Company
Deck Type
Deck date
January 2022
Slide
11 of 39
Related slides by other companies
ATAI
Investor Presentation
March 2023
may increase patient accessibility by reducing patient and clinic time commitment | ATAI
ATAI
Investor Presentation
February 2023
may increase patient accessibility by reducing patient and clinic time commitment | ATAI
ATAI
Investor Presentation
November 2022
we aim to develop as a rapid acting with potential for at home use | ATAI
ATAI
Investor Presentation
January 2023
may increase patient accessibility by reducing patient and clinic time commitment | ATAI
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io